Lingjie Pharmaceutical Co., Ltd. is a national high-tech enterprise integrating R&D, production, sales and service of pharmaceuticals, medical devices, sanitary products and fast-moving consumer goods. Subsidiary companies of Lingjie Pharmaceutical., Ltd: Guangzhou Lingjie Pharmaceutical Co., Ltd., Guangzhou Lingjie E-Commerce Co., Ltd.

The culture of Lingjie pharmaceutical company: Quality-oriented, Integrity first, Respect, Innovation.

Lingjie Pharmaceuticals was established in 2003. In the spirit of people-oriented and serving the society, we are committed to continuously developing and promoting new high-tech products in order to improve the quality of human life; we are committed to continuous innovation to make our products exceed the standards of the people. Expectation, service exceeding the expectations of the people; committed to the rapid development of the company, providing better treatment and career development for employees, creating better benefits for shareholders, and ultimately giving back to the society better.

With the continuous efforts of the company's R&D department, the following results have been achieved:

Scientific research transformation achievement projects:

Disposable humidification bottle nasal oxygen tube: for medical units to humidify and transmit oxygen for patients when inhaling oxygen. It has eight product advantages and three core patents.

Hypertonic & Physiological Seawater Nasal Spray: Physiotherapy for rhinitis, no stimulation and no side effects, can be used for a long time, and has applied for an invention patent.

Gum irrigator, female medical vaginal irrigator, oral antibacterial solution, high-efficiency sterilization and disinfection solution, high-efficiency sterilization and no-clean disinfection gel, female antibacterial solution, etc.

Part of the scientific research projects of transformation results: active enzyme treatment of diabetes, active enzyme wound treatment.

In research and development of scientific research projects: active enzymes inhibit the growth of cancer cells.

With the joint efforts of the company team, the company's business has developed rapidly in recent years, and the scale of the company has continued to grow. In 2018, the company settled in the Economic Headquarters Park of Guangzhou Economic Development Zone, providing new development for the company's strategy of opening up the international market and financing listing in the next step.